Clinical Trial Update: Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 trial investigates a three-drug combination (bendamustine, clofarabine, and etoposide) in younger patients with relapsed or refractory hematologic mal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Clolar (Clofarabine)
• Treanda (Bendamustine)
• VePesid (etoposide)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Hodgkin Lymphoma, Non-Hodgkin Lymphoma | Phase 1 | Status: COMPLETED